Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool... see more

TSXV:CVM.H - Post Discussion

CVR Medical Corp > Absolute disgrace
View:
Post by Looneytunes on Apr 20, 2021 11:04am

Absolute disgrace

Global are getting 57 million shares PLUS 25 million warrants at 10c PLUS an enormous 8% royalty on everything . . .Rhodes has just rolled over and allowed Bakema to screw us all and then has the audacity to try and sell it as a good deal . . . wtf
Comment by Nastro on Apr 20, 2021 11:59am
Warrants for this is beyond stupid.  They are usually given out to encourage investors to take part in a placement not this sort of egregious deal.  Be amazed if they can get funding let alone get it through the AGM.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities